Genmab — November 2016
-
-
Pæn opjustering
-
Markedet får mindre og mindre at se frem til af kurstriggere..
-
ja salget vil hamre i vejret i 2017
-
Jeg var mere usikker. Har hele tiden bare sagt ultimo november.
(daratumumab) injektion til intravenøs infusion er godkendt i USA til behandling af patienter med myelomatose, som har gennemgået mindst tre tidligere behandlingsforløb..."Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind